Settings Today

US approves Alzheimer’s drug designed to slow cognitive decline

The approval has been welcomed by the ASI as a 'significant step' for early Alzheimer's treatment, but adverse affects have been noted from the drug's clinical trials.Read more: US approves Alzheimer’s drug designed to slow cognitive decline

Published 843 days ago

Go Back to Reading NewsBack Read News Collect this News Article

Login to Continue, We will bring you back to this content 0



For peering opportunity Autonomouse System Number: AS401345 Custom Software Development at ErnesTech Email Address[email protected]